This study was initiated to develop inhibitors of the intestinal H+/peptide
symporter. We provide evidence that the dipeptide derivative Lys[Z(NO2)]-P
ro is an effective competitive inhibitor of mammalian PEPT1 with an apparen
t binding affinity of 5-10 muM. Characterization of the interaction of Lys[
Z(NO2)]-Pro with the substrate binding domain of PEPT1 has been performed i
n (a) monolayer cultures of human Caco-2 cells expressing PEPT1, (b) transg
enic Pichia pastoris cells expressing PEPT1, and (c) Xenopus laevis oocytes
expressing PEPT1. By competitive uptake studies with radiolabeled dipeptid
es, HPLC analysis of Lys[Z(NO2)]-Pro in cells, and electrophysiological tec
hniques, we unequivocally show that Lys[Z(NO2)]-Pro binds with high affinit
y to PEPT1, competes competitively with various dipeptides for uptake into
cells, but is not transported itself. Lack of transport was substantiated b
y the absence of Lys[Z(NO2)]-Pro in Caco-2 cell extracts as determined by H
PLC analysis, and by the absence of any positive inward currents in oocytes
when exposed to the inhibitor. The fact that Lys[Z(NO2)]-Pro can bind to P
EPT1 from the extracellular as well. as the intracellular site was shown in
the oocyte expression system by a strong inhibition of dipeptide-induced c
urrents under voltage clamp conditions. Our findings serve as a starting po
int for the identification of the substrate binding domain in the PEPT1 pro
tein as well as for studies on the physiological and pharmacological role o
f PEPT1.